No Data
This Thursday marks the start of the "soul negotiation" for medical insurance. Which companies are likely to be selected?
According to the National Medical Insurance Administration, a press conference will be held at 10 a.m. on November 28 at the National Medical Insurance Administration to announce the adjustments to the national medical insurance pharmaceutical catalog for 2024 and answer questions from reporters. This means that the results of the national negotiation for medical insurance centralized purchasing in 2024 will be announced this Thursday.
Many innovative drugs stocks in Hong Kong suddenly soared!
On the morning of November 25, the hang seng index fell slightly, while the Hong Kong stock market's biomedical sector performed well. Notably, several biomedical companies saw their stock prices rise significantly due to recent news of major collaboration advancements.
Insiders Of CARsgen Therapeutics Holdings Are Up 18% On Their CN¥12.7m Purchase
CARsgen Therapeutics Grants 2.7 Million Options to 31 Employees
Kojin Pharma-B (02171) has granted 2.667 million stock options.
Kojie Pharmaceutical-B (02171) announced that on November 18, 2024, the company will repurchase shares following its initial public offering...
The stock price shows "restlessness". Keji Pharmaceutical announced the trial data of its generic CAR-T product, stating that the company will actively expand overseas.
①The trial data of generic CAR-T product CT0590 from Keji Pharmaceutical has attracted the attention of a large number of investors, and the stock price has surged for two consecutive trading days; ②If generic CAR-T products are approved for marketing, CAR-T drugs may no longer be "sky-high"; ③Keji Pharmaceutical told the Financial Connection journalist that the company will actively promote products going global.
No Data
No Data